Common use of Contract Components Clause in Contracts

Contract Components. 14.1 The following documents constitute integral components of the Funding Contract:  the grant application (“Development of innovative cancer immunotherapies based on Hookipa’s Vaxwave® technology”) received via eCall in the version from 10/01/2014  General Funding Conditions for Funding Contracts as amended (version 1 from 2013)  Guide for Individual Projects of Experimental Development, version 2.0  Cost Guideline to treating project costs in grant applications and reports for projects with grant agreements according to the FTE Guidelines and the FFG Guidelines, version 1.4

Appears in 1 contract

Samples: HOOKIPA Pharma Inc.

AutoNDA by SimpleDocs

Contract Components. 14.1 The following documents constitute integral components of the Funding Contract:  the The grant application (“Development Demonstration of innovative cancer immunotherapies based on the applicability of Hookipa’s Vaxwave® technologyarenaviral vector technologies for cancer immunotherapy development”) received submitted via eCall in the version from 10/01/2014 12/21/2017  General Funding Conditions for Funding Contracts as amended (version 1 from 20132015)  Guide for Individual Projects of Experimental Development, version 2.0 3.3  Cost Guideline to treating project costs in grant applications and reports for projects with grant agreements according to the FTE Guidelines and the FFG Guidelines, version 1.42.1

Appears in 1 contract

Samples: HOOKIPA Pharma Inc.

Contract Components. 14.1 The following documents constitute integral components of the Funding Contract:  the The grant application (“Development Demonstration of innovative cancer immunotherapies based on the applicability of Hookipa’s Vaxwave® technologyarenaviral vector technologies for cancer immunotherapy development”) received submitted via eCall in the version from 10/01/2014 07/07/2016.  General Funding Conditions for Funding Contracts as amended (version 1 from 20132015)  Guide for Individual Projects of Experimental Development, version 2.0 3.1  Cost Guideline to treating project costs in grant applications and reports for projects with grant agreements according to the FTE Guidelines and the FFG Guidelines, version 1.42.0

Appears in 1 contract

Samples: HOOKIPA Pharma Inc.

Contract Components. 14.1 The following documents constitute integral components of the Funding Contract: · the grant application (“Development of innovative cancer immunotherapies based on Hookipa’s Vaxwave® technology”) received via eCall in the version from 10/01/2014 · General Funding Conditions for Funding Contracts as amended (version 1 from 2013) · Guide for Individual Projects of Experimental Development, version 2.0 · Cost Guideline to treating project costs in grant applications and reports for projects with grant agreements according to the FTE Guidelines and the FFG Guidelines, version 1.4

Appears in 1 contract

Samples: HOOKIPA Pharma Inc.

AutoNDA by SimpleDocs

Contract Components. 14.1 The following documents constitute integral components of the Funding Contract:  the · The grant application (“Development Demonstration of innovative cancer immunotherapies based on the applicability of Hookipa’s Vaxwave® technologyarenaviral vector technologies for cancer immunotherapy development”) received submitted via eCall in the version from 10/01/2014  07/07/2016. · General Funding Conditions for Funding Contracts as amended (version 1 from 20132015) · Guide for Individual Projects of Experimental Development, version 2.0  3.1 · Cost Guideline to treating project costs in grant applications and reports for projects with grant agreements according to the FTE Guidelines and the FFG Guidelines, version 1.42.0

Appears in 1 contract

Samples: HOOKIPA Pharma Inc.

Contract Components. 14.1 The following documents constitute integral components of the Funding Contract:  the · The grant application (“Development Demonstration of innovative cancer immunotherapies based on the applicability of Hookipa’s Vaxwave® technologyarenaviral vector technologies for cancer immunotherapy development”) received submitted via eCall in the version from 10/01/2014  12/21/2017 · General Funding Conditions for Funding Contracts as amended (version 1 from 20132015) · Guide for Individual Projects of Experimental Development, version 2.0  3.3 · Cost Guideline to treating project costs in grant applications and reports for projects with grant agreements according to the FTE Guidelines and the FFG Guidelines, version 1.42.1

Appears in 1 contract

Samples: HOOKIPA Pharma Inc.

Time is Money Join Law Insider Premium to draft better contracts faster.